HCMT
PTLA

Highland Capital Management (Texas)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Highland Capital Management (Texas)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.17M Buy
+80,000
New +$2.51M 0.13% 145

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Highland Capital Management (Texas)'s PTLA Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 2.2% in Q2 2019, buying an estimated $1.07M and bringing the position to 1,592,979 shares worth $43.2M. The position accounts for 2.53% of the portfolio, ranked #7.

Highland Capital Management (Texas) first reported a position in PTLA in Q4 2013 and has held it in 19 quarters since. The position peaked at $54.1M in Q1 2019. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

  • Highland Capital Management (Texas) held 1,592,979 shares of Portola Pharmaceuticals, Inc. worth $43.2M as of Q2 2019.
  • Highland Capital Management (Texas) bought 34,150 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.07M.
  • Portola Pharmaceuticals, Inc. made up 2.53% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #7 holding.
  • Highland Capital Management (Texas) first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and has held it in 19 quarters since.
  • Highland Capital Management (Texas)'s Portola Pharmaceuticals, Inc. position peaked at $54.1M in Q1 2019.
  • 202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.